High-priced specialty drugs dominated the market for new drugs in 2015 and 2016, both in Canada and internationally, continuing a trend that has been evident since 2009.
Marketers associated with one pharmacy recruited dentists, physicians, nurse practitioners and others to writing bogus prescriptions to patients they never examined